95 related articles for article (PubMed ID: 11878100)
1. [Misuse and or overdose of BCG vaccine: evaluation over a 4-year period].
Benamar F; Loupi E
Therapie; 2001; 56(6):739-42. PubMed ID: 11878100
[TBL] [Abstract][Full Text] [Related]
2. [French survey about intradermal BCG SSI adverse events in children under 6 years of age].
Dommergues MA; de la Rocque F; Dufour V; Floret D; Gaudelus J; Guérin N; Le Sage FV; Bocquet A; Cohen R
Arch Pediatr; 2007 Jan; 14(1):102-8. PubMed ID: 17140780
[TBL] [Abstract][Full Text] [Related]
3. [Surveillance of the safety of intravesical BCG therapy in France: quantitative analysis of serious adverse events notified over a period of five years].
Debois H; Loupi E; Saliou P
Prog Urol; 2002 Sep; 12(4):604-8. PubMed ID: 12463118
[TBL] [Abstract][Full Text] [Related]
4. [Evaluation of tolerance to endovesical BCG treatment in France: analysis of severe adverse effects notified in 3 years].
Debois H; Loupi E; Saliou P; Blangy H; Loeuille D; Gillet P
Prog Urol; 2001 Jun; 11(3):458-65. PubMed ID: 11512458
[TBL] [Abstract][Full Text] [Related]
5. [Severe adverse reactions after vaccination with Japanese BCG vaccine: a review].
Toida I; Nakata S
Kekkaku; 2007 Nov; 82(11):809-24. PubMed ID: 18078106
[TBL] [Abstract][Full Text] [Related]
6. Safety of anthrax vaccine: a review by the Anthrax Vaccine Expert Committee (AVEC) of adverse events reported to the Vaccine Adverse Event Reporting System (VAERS).
Sever JL; Brenner AI; Gale AD; Lyle JM; Moulton LH; West DJ;
Pharmacoepidemiol Drug Saf; 2002; 11(3):189-202. PubMed ID: 12051118
[TBL] [Abstract][Full Text] [Related]
7. [Adverse events following immunization with BCG vaccine in Poland 1994-2000].
Szczuka I
Przegl Epidemiol; 2002; 56(2):205-16. PubMed ID: 12371352
[TBL] [Abstract][Full Text] [Related]
8. [Granuloma annulare following BCG vaccination].
Houcke-Bruge C; Delaporte E; Catteau B; Martin De Lassalle E; Piette F
Ann Dermatol Venereol; 2001 Apr; 128(4):541-4. PubMed ID: 11395655
[TBL] [Abstract][Full Text] [Related]
9. Adverse events after inactivated influenza vaccination among children less than 2 years of age: analysis of reports from the vaccine adverse event reporting system, 1990-2003.
McMahon AW; Iskander J; Haber P; Chang S; Woo EJ; Braun MM; Ball R
Pediatrics; 2005 Feb; 115(2):453-60. PubMed ID: 15687455
[TBL] [Abstract][Full Text] [Related]
10. Adverse reactions to Mycobacterium bovis bacille Calmette-Guérin (BCG) vaccination against tuberculosis in humans, veterinary animals and wildlife species.
Murphy D; Corner LA; Gormley E
Tuberculosis (Edinb); 2008 Jul; 88(4):344-57. PubMed ID: 18222731
[TBL] [Abstract][Full Text] [Related]
11. [Systemic BCG reactions after intravesical BCG therapy. A report of four cases].
Sfaxi M; Langar H; Ouni A; Riahi Y; El Aidli S; Daghfous R; Ben Abdeladhim A; Chébil M
Therapie; 2008; 63(1):43-7. PubMed ID: 18387275
[TBL] [Abstract][Full Text] [Related]
12. [Safety BCG vaccinations--adverse effects following immunization. Part I. Types, occurrence and registrations].
Szczuka I
Przegl Epidemiol; 2002; 56(1):1-13. PubMed ID: 12150052
[TBL] [Abstract][Full Text] [Related]
13. Botulinum toxin type A injections: adverse events reported to the US Food and Drug Administration in therapeutic and cosmetic cases.
Coté TR; Mohan AK; Polder JA; Walton MK; Braun MM
J Am Acad Dermatol; 2005 Sep; 53(3):407-15. PubMed ID: 16112345
[TBL] [Abstract][Full Text] [Related]
14. Safety of anthrax vaccine: an expanded review and evaluation of adverse events reported to the Vaccine Adverse Event Reporting System (VAERS).
Sever JL; Brenner AI; Gale AD; Lyle JM; Moulton LH; Ward BJ; West DJ
Pharmacoepidemiol Drug Saf; 2004 Dec; 13(12):825-40. PubMed ID: 15386719
[TBL] [Abstract][Full Text] [Related]
15. The predictive value of purified protein derivative results on complications and prognosis in patients with bladder cancer treated with bacillus Calmette-Guerin.
Bilen CY; Inci K; Erkan I; Ozen H
J Urol; 2003 May; 169(5):1702-5. PubMed ID: 12686812
[TBL] [Abstract][Full Text] [Related]
16. Too much of a good thing: management of BCG vaccine overdose.
Ritz N; Tebruegge M; Streeton J; Curtis N
Vaccine; 2009 Sep; 27(41):5562-4. PubMed ID: 19654063
[TBL] [Abstract][Full Text] [Related]
17. Complications of BCG vaccine SSI® recent story and risk management plan: the French experience.
Chol C; Guy C; Jacquet A; Castot-Villepelet A; Kreft-Jais C; Cambazard F; Beyens MN; Mounier G; Marsille F; Mismetti P
Pharmacoepidemiol Drug Saf; 2013 Apr; 22(4):359-64. PubMed ID: 23213021
[TBL] [Abstract][Full Text] [Related]
18. BCG vaccine-associated suppurative lymphadenitis.
Teo SS; Smeulders N; Shingadia DV
Vaccine; 2005 Apr; 23(20):2676-9. PubMed ID: 15780451
[TBL] [Abstract][Full Text] [Related]
19. [Tuberculosis in compromised hosts].
Kekkaku; 2003 Nov; 78(11):717-22. PubMed ID: 14672050
[TBL] [Abstract][Full Text] [Related]
20. [BCG infection of the glans penis after intravesical BCG therapy].
Michelet N; Spenatto N; Viraben R; Cuny JF; Mazet J; Trechot P; Barbaud A; Schmutz JL
Ann Dermatol Venereol; 2008; 135(6-7):479-83. PubMed ID: 18598797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
